Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.2mg/500mg/40mg Tablet
Marketer
Swast Aushadhi Seva Generic Medicine Store
Salt Composition
Voglibose (0.2mg) + Metformin (500mg) + Gliclazide (40mg)
Overview Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.2mg/500mg/40mg Tablet
This triple-combination tablet, containing Voglibose 0.2mg, Metformin Hydrochloride 500mg, and Gliclazide 40mg, is an antidiabetic medication for adult patients with type 2 diabetes. It's designed to manage blood glucose levels. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage adjustments will be determined by your physician based on your blood sugar readings. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to dangerously elevated glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan, also requiring a healthy diet, exercise, and weight management as directed by your doctor. Commonly reported side effects include hypoglycemia (low blood sugar). Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and always carry a fast-acting sugar source. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects are altered taste perception, nausea, vomiting, diarrhea, abdominal discomfort, headache, edema, blurred vision, and bone fractures. Weight gain is also possible. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women should seek medical advice before use. Regular blood glucose monitoring is essential, along with periodic blood tests to track blood cell counts and liver function.
Uses of Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.2mg/500mg/40mg Tablet
Managing type 2 diabetes
Major Benefits of Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.2mg/500mg/40mg Tablet:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.2mg/500mg/40mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
Common Side effects of Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.2mg/500mg/40mg Tablet:
- Nausea
- Hypoglycemia (low blood glucose level)
- Abdominal pain
- Constipation
How to use Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.2mg/500mg/40mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.2mg/500mg/40mg tablets should be administered with meals.
How Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.2mg/500mg/40mg Tablet works:
Voglibose, metformin hydrochloride, and gliclazide (0.2mg/500mg/40mg) tablets, marketed as Genericart, offer a triple-drug approach to diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.2mg/500mg/40mg tablets poses a significant safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Voglibose, Metformin Hydrochloride, and Gliclazide (0.2mg/500mg/40mg) combination tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks before recommending this medication. Physician consultation is advised.
Breast feedingCAUTION
Voglibose, metformin hydrochloride, and gliclazide (Genericart 0.2mg/500mg/40mg) tablets require careful consideration during lactation. Mothers should discontinue breastfeeding until treatment concludes and the medication is fully cleared from their system.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Voglibose/Metformin Hydrochloride/Gliclazide 0.2mg/500mg/40mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated in individuals with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver disease should use Voglibose+Metformin Hydrochloride+Gliclazide 0.2mg/500mg/40mg tablets cautiously. Dosage modification may be necessary. Consult a physician. For those with mild to moderate liver impairment, treatment should begin with a low dose; it's contraindicated in patients with severe liver disease.
What if you forget to take Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.2mg/500mg/40mg Tablet :
NA
Facts to Know About Genericart Voglibose+Metformin Hydrochloride+Gliclazide 0.2mg/500mg/40mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
3,018 People bought this recently